logo
15:59 Jul 08

Aurobindo Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1557.40
-25.70 (-1.62%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Aurobindo Pharma Ltd. Financials

Aurobindo Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1557.40
-25.70 (-1.62%)
15:59 Jul 08
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

42/100
Mid Valuation

Technical

67/100
Technically Moderately Bullish

Strength

8

Weakness

4

Opportunity

1

Threats

1

9.24 %

ROE %

5.99 %

ROA %

64.26

EPS

652.39

BVPS

10.41 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
23455.49 24855.38 29001.87 31723.73 33653.08
Operating Expenses +
19068.72 21136.74 23158.87 25140.94 26807.35
Raw Material
9323.6 11702.94 13549.07 13623.87 13783.17
Increase Decrease in Cost
816.68 -409.68 -946.17 -597.63 -294.81
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
3450.92 3522.25 3922.94 4475.62 5190.17
Miscellaneous Expenses
9381.06 10422.09 12178.89 13413.3 15084.78
Operating Profit
4386.77 3718.64 5843 6582.79 6845.73
Other Income
320.35 290.59 557.38 621.85 492.09
Depreciation
1126.52 1244.58 1521.66 1649.42 1778.19
Interest
48.64 140.48 289.71 457.24 383.97
Profit before tax and exceptio..
3531.96 2624.17 4589.01 5097.98 5175.66
Exceptional Items
-127.97 0 -191.86 0 -65.33
PBT
3403.99 2624.17 4397.15 5097.98 5110.33
Provision for Taxation
725.63 684.85 1211.02 1582.72 1608.88
Net Profit
2678.36 1939.32 3186.13 3515.26 3501.45
NET Profit after MI
2648.15 1927.5 3172.97 3485.88 3504.75
EPS
45.19 32.9 54.16 59.81 60.34
Operating Profit Margin (%)
18.7 14.96 20.15 20.75 20.34
Net Profit Margin (%)
11.29 7.75 10.94 10.99 10.41

Aurobindo Pharma Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: